Stockscreener 앱 받기
0.581
1.97%
-0.0117
시간 외 거래:
.59
0.009
+1.55%
전일 마감가:
$0.5927
열려 있는:
$0.59
하루 거래량:
35,990
Relative Volume:
0.10
시가총액:
$5.31M
수익:
$11.42M
순이익/손실:
$-2.89M
주가수익비율:
-1.5249
EPS:
-0.381
순현금흐름:
$-1.38M
1주 성능:
+10.46%
1개월 성능:
-0.02%
6개월 성능:
-64.36%
1년 성능:
-73.47%
1일 변동 폭
$0.58
$0.60
1주일 범위
$0.53
$0.6252
52주 변동 폭
$0.4811
$2.8899
Nexgel Inc Stock (NXGL) Company Profile
명칭
Nexgel Inc
전화
215 702-8550
주소
2150 CABOT BLVD WEST,, LANGHORNE
Compare NXGL vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NXGL
Nexgel Inc
|
0.581 | 5.41M | 11.42M | -2.89M | -1.38M | -0.381 |
ISRG
Intuitive Surgical Inc
|
402.30 | 146.01B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.43 | 40.04B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
64.28 | 32.04B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
33.19 | 30.23B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
182.82 | 27.04B | 5.54B | 1.52B | 1.74B | 10.37 |
Nexgel Inc 주식(NXGL)의 최신 뉴스
Number of shareholders of NexGel, Inc – BOATS:NXGL - TradingView
NexGel Inc stock (US65340W1027): shares hover near 52-week lows as investors await fresh catalysts - AD HOC NEWS
Nexgel CEO Adam Levy sells 13,000 shares for $7,834 By Investing.com - Investing.com India
Nexgel CEO Adam Levy sells 13,000 shares for $7,834 - Investing.com UK
NEXGEL (NASDAQ: NXGL) CEO Adam R. Levy sells 13,000 shares in open market trades - Stock Titan
NexGel Inc (NXGL) Holds Near Support After Marginal DeclineLarge Cap Trends - thelegaladvocate.com
NexGel Inc (NXGL) Hovers Near Support Amid Minimal Price MovementIV Rank - thelegaladvocate.com
NexGel (NXGL) asks shareholders to clear potential >19.99% dilution from convertibles - Stock Titan
NXGL Q1 2026 Earnings: EPS Misses Estimates by Wide Margin Amid Operational ChallengesEarnings Risk Report - The Legal Advocate
[144] NEXGEL, INC. SEC Filing - Stock Titan
NexGel Inc stock (US65340W1027): hydrogel specialist with micro-cap profile on Nasdaq - AD HOC NEWS
NEXGEL Study Targets Safety Risks in Laser Hair Removal - MyChesCo
NexGel Inc (NXGL) Q1 2026 Earnings: EPS Miss on Higher Operating CostsDownward Estimate Revision - newsline.com
NexGel Inc (NXGL) Q1 2026 Earnings: EPS Misses Estimates as Losses WidenShort-Term Outlook - Newser
Langhorne’s Nexgel transforms near disaster into ‘three-team trade’ acquisition - MSN
NexGel Inc (NXGL) Shows Modest Gains, Trading Near Support LevelsOBV Breakout - Newser
NEXGEL Hires Medtech Executive to Expand Surgical Unit - MyChesCo
NXGL Should I Buy - Intellectia AI
NXGL SEC FilingsNexgel Inc 10-K, 10-Q, 8-K Forms - Stock Titan
NXGL Stock Price, Quote & Chart | NEXGEL INC (NASDAQ:NXGL) - ChartMill
Maxim Group Maintains NexGel(NXGL.US) With Buy Rating, Maintains Target Price $2 - Moomoo
NexGel Inc stock (US65340W1027): clinical laser study puts hydrogel specialist in focus - AD HOC NEWS
Nexgel hydrogel patch reduces laser plume in hair removal study By Investing.com - Investing.com South Africa
Nexgel hydrogel patch reduces laser plume in hair removal study - Investing.com
NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration - GlobeNewswire
Director boosts NEXGEL (NXGL) exposure with convertible note and warrant - Stock Titan
NEXGEL (NXGL) director buys $1M convertible note and stock warrant - Stock Titan
NEXGEL (NXGL) CEO acquires convertible note and 50,000-share stock warrant - Stock Titan
NEXGEL (NXGL) director Harris Kevin McClain listed on Form 3 - Stock Titan
NEXGEL (NASDAQ: NXGL) director lists warrant and note positions - Stock Titan
NexGel Inc stock (US65340W1027): Q1 2026 numbers put hydrogel growth story in focus - AD HOC NEWS
NEXGEL, Inc. (NASDAQ:NXGL) Q1 2026 Earnings Call Transcript - Insider Monkey
Nexgel Earnings Call: BioNX Bet Amid Cash Strain - TipRanks
NexGel Raises Insider-Funded Convertible Notes to Bolster Liquidity - TipRanks
NEXGEL Adds Sequence Executives to Board After Deal Financing - MyChesCo
NexGel Raises $1.21 Million Via Convertible Notes and Warrants; $0.60 Conversion, $0.80 Exercise - TradingView
NexGel (NASDAQ: NXGL) sells $1.21M in convertible notes with warrants - Stock Titan
Nexgel (NXGL) Q1 2026 Earnings Transcript - The Globe and Mail
NXGL: BioNX acquisition set to triple annual revenue and drive immediate profitability - TradingView
Earnings call transcript: Nexgel Q1 2026 reveals revenue decline, stock dips - Investing.com India
Earnings call transcript: Nexgel Q1 2026 reveals revenue decline, stock dips By Investing.com - Investing.com South Africa
NXGL: BioNX acquisition set to triple revenue and drive profitability as legacy business stabilizes - TradingView
NexGel Q1 2026 Earnings Call Transcript - Benzinga
Nexgel Inc reports results for the quarter ended March 31Earnings Summary - TradingView
NXGL: Q1 2026 saw revenue down 5.6%, a $927K net loss, and a major acquisition funded by new capital - TradingView
NEXGEL, INC. 1Q 2026: Revenue $2.65M, EPS $(0.11) — 10-Q Summary - TradingView
NexGel (NASDAQ: NXGL) posts Q1 2026 loss and flags going concern risks amid new debt - Stock Titan
NEXGEL, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
NexGel Inc (NXGLW) Stock: Consolidating at $$0.05 — Next Move Ahead 2026-05-14Sector Leader - newser.com
Nexgel appoints Dave Hazard as VP of sales for BIONX Surgical By Investing.com - Investing.com India
NEXGEL, Inc. announced that it has received $1.21 million in funding - marketscreener.com
Nexgel Inc (NXGL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.52%
1.16%
자본화:
|
볼륨(24시간):